Novocure Ltd (NASDAQ: NVCR) is a medical device company that develops and commercializes Tumor Treating Fields (TTFields), an electric field-based therapy for cancer treatment. Revenue is generated primarily through the rental and sale of its TTFields delivery systems to patients and healthcare providers on a per-prescription basis. The filing excerpts provided do not contain sufficient detail to describe segment revenue breakdowns, geographic mix, customer concentration, competitor names, leadership tenure, founding year, or unit economics. All such details have been omitted to avoid unsupported inference.

Revenue model

The filing excerpts do not provide sufficient detail to describe Novocure's revenue model with sourced specifics.

Products and services

Tumor Treating Fields (TTFields) therapy and associated delivery systems.

Customers and end markets

The filing excerpts do not provide sufficient detail to describe customer types or end markets with sourced specifics.

Value-chain role

Medical device developer and commercial-stage therapy provider.

Geographic exposure

The filing excerpts do not provide sufficient geographic detail to describe regional revenue mix.

Source: SEC 10-K, filed 2026-02-26

Industry: Surgical & Medical Instruments & Apparatus